Latest Insider Transactions at Idera Pharmaceuticals, Inc. (IDRA)
This section provides a real-time view of insider transactions for Idera Pharmaceuticals, Inc. (IDRA). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of IDERA PHARMACEUTICALS, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of IDERA PHARMACEUTICALS, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 10
2023
|
Maxine Gowen |
SELL
Open market or private sale
|
Indirect |
51
-100.0%
|
$0
$0.51 P/Share
|
|
Aug 10
2023
|
Vincent Milano |
SELL
Open market or private sale
|
Direct |
3,283
-26.76%
|
$0
$0.53 P/Share
|
|
Jul 13
2023
|
Pillar Invest Corp > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,213
-1.32%
|
$2,213
$1.54 P/Share
|
|
Jul 12
2023
|
Pillar Invest Corp > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,605
-2.11%
|
$3,605
$1.58 P/Share
|
|
May 17
2023
|
Pillar Invest Corp > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
26,965
+13.64%
|
$26,965
$1.42 P/Share
|
|
May 17
2023
|
Atul Chopra > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
24,800
-0.34%
|
$24,800
$1.34 P/Share
|
|
May 16
2023
|
Atul Chopra > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,436
-0.65%
|
$32,436
$1.42 P/Share
|
|
May 15
2023
|
Atul Chopra > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
78,436
-0.4%
|
$78,436
$1.47 P/Share
|
|
May 12
2023
|
Atul Chopra > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
81,486
-0.28%
|
$81,486
$1.61 P/Share
|
|
May 11
2023
|
Atul Chopra > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
47,166
-0.16%
|
$47,166
$1.85 P/Share
|
|
Jan 17
2023
|
John Clayton Taylor CHIEF EXECUTIVE OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,341,764
+47.73%
|
-
|
|
Jan 17
2023
|
Daniel Salain CHIEF OPERATING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,341,764
+47.73%
|
-
|
|
Jan 17
2023
|
Andrew R Jordan CHIEF STRATEGY OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
402,529
+47.11%
|
-
|
|
Jan 11
2023
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
33,523
+8.2%
|
$0
$0.44 P/Share
|
|
Jan 06
2023
|
John J. Kirby CHIEF FINANCIAL OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
119,957
-27.46%
|
$0
$0.71 P/Share
|
|
Jan 06
2023
|
John J. Kirby CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
399,218
+47.75%
|
-
|
|
Jan 06
2023
|
Bryant David Lim SVP AND GENERAL COUNSEL |
SELL
Payment of exercise price or tax liability
|
Direct |
119,957
-27.92%
|
$0
$0.71 P/Share
|
|
Jan 06
2023
|
Bryant David Lim SVP AND GENERAL COUNSEL |
BUY
Grant, award, or other acquisition
|
Direct |
399,218
+48.16%
|
-
|
|
Jan 06
2023
|
Andrew R Jordan CHIEF STRATEGY OFFICER |
SELL
Payment of exercise price or tax liability
|
Direct |
73,940
-8.1%
|
$0
$0.71 P/Share
|
|
Jan 06
2023
|
Andrew R Jordan CHIEF STRATEGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
261,718
+22.28%
|
-
|
|
Oct 03
2022
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
58,516
+14.62%
|
$0
$0.37 P/Share
|
|
Sep 28
2022
|
Nova Quest Co Investment Fund Xv, L.P. Director |
BUY
Other acquisition or disposition
|
Direct |
5
+50.0%
|
-
|
|
Sep 28
2022
|
Ronald J Wooten Director |
BUY
Other acquisition or disposition
|
Indirect |
5
+50.0%
|
-
|
|
Sep 28
2022
|
John Clayton Taylor CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,171,214
+50.0%
|
-
|
|
Sep 28
2022
|
Daniel Salain CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,171,214
+50.0%
|
-
|
|
Sep 28
2022
|
Andrew R Jordan CHIEF STRATEGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
651,364
+50.0%
|
-
|
|
Sep 22
2022
|
Pillar Invest Corp > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,533,159
+17.42%
|
$0
$0.01 P/Share
|
|
Jul 01
2022
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
50,086
+15.03%
|
$0
$0.44 P/Share
|
|
Apr 01
2022
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
41,155
+15.01%
|
$0
$0.54 P/Share
|
|
Jan 03
2022
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
37,062
+16.19%
|
$0
$0.59 P/Share
|
|
Dec 17
2021
|
John J. Kirby CHIEF FINANCIAL OFFICER |
BUY
Open market or private purchase
|
Direct |
10,000
+20.99%
|
$0
$0.62 P/Share
|
|
Oct 04
2021
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
21,229
+12.06%
|
$21,229
$1.03 P/Share
|
|
Jun 18
2021
|
Daniel B Soland CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
50,000
+38.81%
|
$50,000
$1.19 P/Share
|
|
Jun 01
2021
|
Michael R Dougherty |
BUY
Open market or private purchase
|
Direct |
85,000
+38.89%
|
$85,000
$1.19 P/Share
|
|
Apr 01
2021
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
10,939
+18.38%
|
$10,939
$1.32 P/Share
|
|
Apr 01
2021
|
James A Geraghty |
BUY
Grant, award, or other acquisition
|
Direct |
14,773
+11.0%
|
$14,773
$1.32 P/Share
|
|
Apr 01
2021
|
Mark Alan Goldberg |
BUY
Grant, award, or other acquisition
|
Direct |
10,511
+17.78%
|
$10,511
$1.32 P/Share
|
|
Apr 01
2021
|
Carol Schafer |
BUY
Grant, award, or other acquisition
|
Direct |
11,177
+15.78%
|
$11,177
$1.32 P/Share
|
|
Mar 26
2021
|
Pillar Invest Corp > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
2,495,809
+24.06%
|
$0
$0.01 P/Share
|
|
Mar 25
2021
|
John J. Kirby CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
6,250
-18.45%
|
$6,250
$1.42 P/Share
|
|
Mar 25
2021
|
Bryant David Lim SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
7,630
-20.05%
|
$7,630
$1.36 P/Share
|
|
Mar 25
2021
|
Elizabeth Ann Tarka CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,018
-27.49%
|
$5,018
$1.35 P/Share
|
|
Mar 18
2021
|
Pillar Invest Corp > 10% Shareholder |
BUY
Open market or private sale
|
Indirect |
1,699,765
+20.89%
|
$1,699,765
$1.8 P/Share
|
|
Mar 05
2021
|
Daniel B Soland CHIEF OPERATING OFFICER |
BUY
Open market or private purchase
|
Direct |
10,000
+25.74%
|
$30,000
$3.9 P/Share
|
|
Jan 20
2021
|
Pillar Invest Corp > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
643,525
+24.99%
|
$0
$0.01 P/Share
|
|
Jan 12
2021
|
Vincent Milano |
SELL
Open market or private sale
|
Direct |
3,210
-1.52%
|
$12,840
$4.2 P/Share
|
|
Jan 12
2021
|
Bryant David Lim SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
1,711
-4.3%
|
$6,844
$4.21 P/Share
|
|
Jan 12
2021
|
Elizabeth Ann Tarka CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,745
-8.73%
|
$6,980
$4.19 P/Share
|
|
Jan 12
2021
|
John J. Kirby CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,693
-4.76%
|
$6,772
$4.22 P/Share
|
|
Jan 05
2021
|
Vincent Milano |
SELL
Open market or private sale
|
Direct |
2,740
-1.28%
|
$8,220
$3.91 P/Share
|